TABLE 1.
S. aureus strains used in this study
Strain | Relevant feature of the strain | Reference |
---|---|---|
Mu50 | Reduced susceptibility to vancomycin (MIC, 8 μg/ml) | 11 |
Mu3 | Reduced susceptibility to vancomycin (heterogeneousa) | 11 |
Mu50ω | Reduced susceptibility to vancomycin (heterogeneousa) | This study |
N315 | Susceptible to vancomycin, pre-MRSA | 7 |
H1 | Susceptible to vancomycin, MRSA | 11 |
FDA209P | Susceptible to vancomycin, MSSAb type strain | 11 |
BB255 | Equivalent to NCTC8325, MSSA | 11 |
BB270 | NCTC8325 transduced with mec determinant | 5 |
BB589 | femC mutant derived from BB270 | 5 |
Contains subpopulation of cells for which the MIC is 8 μg/ml or greater.
MSSA, methicillin-susceptible S. aureus.